US Patent 8252839 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

United Therapeutics

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

Contact Supplier

Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

xyz-pharma-m-2025-01-06

Contact Supplier

United Therapeutics

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation

Corporate Presentation

DIGITAL CONTENT

INTERVIEW #SpeakPharma, VLOG #PharmaReel, DATA COMPILATION #PharmaFlow, 231 NEWS #PharmaBuzz

INTERVIEW #SpeakPharma
VLOG #PharmaReel
DATA COMPILATION #PharmaFlow
231 NEWS #PharmaBuzz

DEVELOPMENTS

35 Drugs in Development

35 Drugs in Development

FINISHED DOSAGE FORMULATIONS

42 FDF Dossiers, 24 FDA Orange Book, 13 Europe, 5 Canada

42 FDF Dossiers
24 FDA Orange Book
13 Europe
5 Canada

INSPECTIONS & REGISTRATIONS

7 FDA

7 FDA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 5UNITED THERAP

filter Patent Number Reset all filters

5 All

01 58252839

filter API Patent Reset all filters

5 All

01 5Blank

filter FDF Patent Reset all filters

5 All

01 5Y

filter Expiration Date Reset all filters

5 All

01 52024-05-24

01

UNITED THERAP

TREPROSTINIL DIOLAMINE

PharmaVenue

Not Confirmed

UNITED THERAP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-05-24

TREPROSTINIL DIOLAMINE

US Patent Number : 8252839

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-24

Portfolio PDF

Product Web Link

Digital Content

02

UNITED THERAP

TREPROSTINIL DIOLAMINE

PharmaVenue

Not Confirmed

UNITED THERAP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-05-24

TREPROSTINIL DIOLAMINE

US Patent Number : 8252839

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-24

Portfolio PDF

Product Web Link

Digital Content

03

UNITED THERAP

TREPROSTINIL DIOLAMINE

PharmaVenue

Not Confirmed

UNITED THERAP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-05-24

TREPROSTINIL DIOLAMINE

US Patent Number : 8252839

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-24

Portfolio PDF

Product Web Link

Digital Content

04

UNITED THERAP

TREPROSTINIL DIOLAMINE

PharmaVenue

Not Confirmed

UNITED THERAP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-05-24

TREPROSTINIL DIOLAMINE

US Patent Number : 8252839

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-24

Portfolio PDF

Product Web Link

Digital Content

05

UNITED THERAP

TREPROSTINIL DIOLAMINE

PharmaVenue

Not Confirmed

UNITED THERAP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-05-24

TREPROSTINIL DIOLAMINE

US Patent Number : 8252839

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-24

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?